Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
- Professor of Epidemiology
- Institute for Global Health
- Faculty of Pop Health Sciences
Kholoud has worked in HIV since 1986 and leads an epidemiology programme of work in HIV research. She gained an MSc in Medical Statistics at the London School of Hygiene and Tropical Medicine and a PhD in AIDS and HIV Infection at UCL estimating the HIV incubation period distribution through a national HIV cohort.
Her main research interests are in HIV natural history and primary HIV infection. Most of her work has been within industrialised country cohorts although she has also co-ordinated a randomised controlled trial recruiting in Uganda and South Africa and within an international consortium evaluating antiretroviral therapy roll-out programmes in Africa. She was Principal Investigator for the UK Register of HIV Seroconverters and CASCADE, an EU-funded collaboration of HIV seroconverter cohorts. CASCADE then became part of a large Network of Excellence, EuroCoord, which she also led.
Kholoud has collaborated widely within the UK and internationally with colleagues in European, Australian and north American research institutions. She is also Departmental Graduate Tutor.


PhD/MD supervision
Rakan Ekram: “Policy analysis of the carbonated and energy drinks tax in Saudi Arabia”
Adesola Yinka-Ogunleye: “Investigating the epidemiology of Salmonella typhi in Nigeria to inform surveillance and control strategy”
Susan Hoskins: “Monitoring the health of the populationaccessing HIV care in low income countries”
Ruth Simmons: “Estimating HIV incidence in Estonia, Polandand the Ukraine”
Victoria Parsons: “Assessing the potential for onwardtransmission from recent HIV seroconverters, and the role of ART in reducingtransmission in this population”.
Alexandra Lyons: “Serious non-AIDS events (SNAEs) in theHIV-positive population”.
Collins Iwuji: “Will earlier treatment lead to drugresistance of the form and prevalence likely to compromise future eliminationof HIV?”